IBB vs RYLD

iShares Biotechnology ETF vs Global X Russell 2000 Covered Call ETF

Quick take
  • IBB has the lower expense ratio at 0.44% vs 0.60% for RYLD.
  • RYLD pays a higher dividend yield (6.81%).

Side-by-side metrics

MetricIBBRYLD
Expense ratio
Annual fee. Lower is better.
0.44%0.60%
Dividend yield
Trailing 12-month yield.
0.22%6.81%
AUM
Assets under management — bigger funds are typically more liquid.
$9.09B$1.36B
YTD return
16.44%10.76%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.690.54
P/E ratio
24.7918.65
Last price
$196.62$16.05
Inception
Issuer
iSharesGlobal X

IBB top holdings

Top holdings · IBB
VRTXVertex Pharmaceuticals Inc8.07%
AMGNAmgen Inc7.82%
GILDGilead Sciences Inc6.83%
REGNRegeneron Pharmaceuticals Inc4.90%
ARGXargenx SE ADR3.75%
ALNYAlnylam Pharmaceuticals Inc3.12%
NTRANatera Inc2.89%
RVMDRevolution Medicines Inc Ordinary Shares2.78%
BIIBBiogen Inc2.46%
ILMNIllumina Inc2.07%
Sector breakdown · IBB
Healthcare100.0%

RYLD top holdings

Top holdings · RYLD
RSSLGlobal X Russell 2000 ETF102.91%
Sector breakdown · RYLD
Real Estate6.8%
Consumer Cyclical9.2%
Basic Materials4.4%
Consumer Defensive2.6%
Technology14.4%
Communication Services2.2%
Financial Services17.8%
Utilities2.8%
Industrials14.1%
Energy5.5%
Healthcare20.3%

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About RYLD

RYLD (Global X Russell 2000 Covered Call ETF) is Russell 2000 covered call strategy for income. Managed by Global X, the fund carries $1.4B in assets under management, an expense ratio of 0.60%, a dividend yield of 6.81%. Its largest holding is Global X Russell 2000 ETF (RSSL), which represents 102.9% of the portfolio. Real Estate is the fund's largest sector exposure at 6.8%.